North East and North Cumbria
ICS Formulary
 
back
4 Central nervous system
04-07-03 Postherpetic neuralgia

Capsaicin
Formulary

  • Qutenza® cutaneous patch approved for the treatment of neuropathic pain as fourth line agent for neuropathic pain and in line with the attached regionally agreed pathway. Red

  • 0.075% cream (Axsain®) approved for post hepatic neuralgia and peripheral diabetic neuropathy Green plus
Link  NTAG - Treatment Appraisal Decision Summary - Capsaicin (Qutenza)
Link  NTAG Pathway for the use of Qutenza (Capsaicin 8%) in the Neuropathic Pain Patient Group

View adult BNF  View SPC online  View childrens BNF
Lidocaine 5% medicated plasters (700mg lidocaine/plaster)
Formulary

Exception criteria only for use in the treatment of post-herpetic neuralgia only on the advice of specialists and subject to an appropriate trial of efficacy in each individual patient. [GREEN PLUS Status]

 

Primary Care - All other indications for prescribing are 'do not prescribe/not approved'.

See NHSE policy guidance linked below.
Link  NHSE: Items which should not routinely be prescribed in primary care: policy guidance

Red View adult BNF  View SPC online  View childrens BNF